Should you buy, sell or hold HUL, Paytm, Bharti Airtel, Tata Motors, Sona BLW, other stocks now?
Which stocks to buy, hold or sell today? Brokerages are bullish on stocks such as Bharti Airtel, Paytm, Hindustan Unilever, Sona BLW Precision and Tata Motors. Check out the complete list of brokerage recommendations along with the rating as well as target price here.
Brokerages are positive on stocks such as Hindustan Unilever Ltd (HUL), One97 (PAYTM), Sona BLW Precision (SONACOMS), Tata Motors, Sun Pharma and Bharti Airtel, mainly on the the back of a strong business outlook and future growth prospects.
Check out the full list of brokerage calls on Hindustan Unilever, Paytm, Sona BLW Precision, Tata Motors, Sun Pharma, Bharti Airtel and other stocks in focus on Dalal Street:
Morgan Stanley maintains an ‘equal-weight’ rating on Paytm parent One97 Communications with a target price of Rs 695. Citi has a ‘buy’ call on Paytm with a target of Rs 1,061 — implying upside potential of 82.6 per cent from Monday's closing price.
According to Citi, Paytm has several existing and emerging levers and available at an attractive valuation.
|Morgan Stanley||Equal weight||Rs 695|
Sona BLW Precision Forgings (SONACOMS) shares
CLSA maintains a ‘buy’ rating on Sona BLW Precision Forgings but reduces its target price for the auto ancillary stock by Rs 37 to Rs 529.
The brokerage says Blackstone's exit has not changed its thesis, citing the company’s strong and growing order book. Its margin is likely to increase led by production linked incentive (PLI) scheme, it adds.
Bharti Airtel shares
Morgan Stanley is bullish on Bharti Airtel citing the telecom operator's potential 4G tariff hikes and accelerated market share gains. The brokerage maintains an ‘overweight’ rating for Bharti Airtel with a target of Rs 860 per share.
Hindustan Unilever shares
|Credit Suisse||Outperform||Rs 2,950|
Sun Pharma shares
Jefferies has a ‘buy’ rating on Sun Pharma with a target price of Rs 1,200 per share. According to the brokerage, the acquisition of Concert Pharmaceuticals adds a complementary derma product to Sun Pharma's existing specialty portfolio.
Tata Motors shares
Nomura is upbeat on the Tata group auto major on the back of steady growth in the business of its UK-based subsidiary Jaguar and Land Rover's business.
The brokerage has a ‘buy’ rating on Tata Motors with a target price of Rs 508 per share. JLR's order book remains at healthy levels with steady improvements, according to Nomura.
CLSA on Fusion Micro Finance and CreditAccess Grameen
According to CLSA, both Fusion Micro Finance and CreditAccess Grameen have differences in geographies and ticket sizes, and similar incentive structures.
Credit Access Grameen is more productive, but Fusion Micro is catching up by narrowing the gap in asset quality and return on asset/return on equity (RoA/RoE), according to the brokerage.
Here's how CLSA rates these stocks:
|Fusion Micro Finance||Buy||Rs 550|
|CreditAccess Grameen||Buy||Rs 1,250|
Catch latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.